Annual report [Section 13 and 15(d), not S-K Item 405]

Commitments and Contingencies - Contingent Consideration (Details)

v3.26.1
Commitments and Contingencies - Contingent Consideration (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 17, 2025
Sep. 17, 2025
Dec. 31, 2025
Dec. 31, 2024
Commitments and Contingencies        
Exarafenib milestone contingent consideration     $ 3,600 $ 3,214
Contingent consideration adjustment   $ 5,673    
Contingent consideration under RPAs, AAAs, and CPPAs     0 3,000
HilleVax        
Commitments and Contingencies        
Contingent consideration adjustment     5,700  
LAVA        
Commitments and Contingencies        
Contingent consideration adjustment $ 9,114   9,100  
CVR Agreement | Kinnate CVR holders        
Commitments and Contingencies        
Exarafenib milestone contingent consideration     $ 3,600 $ 3,200